Anticorps Recombinant de lapin anti-DAB2
DAB2 Recombinant Antibody for WB, IF/ICC, Cytometric bead array, Indirect ELISA, Sample test
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris
Applications
WB, IF/ICC, Cytometric bead array, Indirect ELISA, Sample test
Conjugaison
Non conjugué
CloneNo.
250409B4
N° de cat : 86141-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
86141-1-PBS cible DAB2 dans les applications de WB, IF/ICC, Cytometric bead array, Indirect ELISA, Sample test et montre une réactivité avec des échantillons Humain, souris
| Réactivité | Humain, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | DAB2 Protéine recombinante Ag0162 |
| Nom complet | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) |
| Masse moléculaire calculée | 82 kDa |
| Poids moléculaire observé | 96 kDa |
| Numéro d’acquisition GenBank | BC003064 |
| Symbole du gène | DAB2 |
| Identification du gène (NCBI) | 1601 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
DAB2 is a protein of 770 amino acid residues with a predicted molecular weight of 85.5kDa. This gene was initially named DOC2 (for Differentially expressed in Ovarian Cancer) and is distinct from the DOC2A and DOC2B genes (for double C2-like domains, alpha and beta). Human DAB2 has an overall 83% identify with the mouse p96 protein, a putative mitogen-responsive phosphoprotein; homology is strongest in the amino-terminal end of the protein in a region corresponding to the phosphotyrosine interaction domain (PID), and contains multiple SH3 binding motifs. Chromosomal localization by FISH showed that the DAB2 gene is located on 5p13. The expression of DAB2 is down-regulated or absent in all the carcinoma cell lines examined, including prostate and ovarian carcinoma cell lines. The N-terminal domain of DAB2 interacts with Dishevelled-3 (Dvl-3), a signaling mediator of the Wnt pathway. Ectopic expression of DAB2 attenuates canonical Wnt/catenin-mediated signaling, including accumulation of catenin and cyclin D1 induction. DAB2 suppresses both protein kinase C and peptide growth factor-elicited signal pathways via the Ras-mitogen-activated protein kinase pathway. The proline-rich domain of DAB2 also interacts with proteins containing SH3 domain, such as Src and Fgr. The binding of DAB2 to c-Src resultes in the inactivation of c-Src. All data suggest that DAB2 is a potent tumor suppressor in many cancer types.











